DK3823972T3 - Imidazo[1,2-b]pyridazinderivater som trk-inhibitorer - Google Patents

Imidazo[1,2-b]pyridazinderivater som trk-inhibitorer Download PDF

Info

Publication number
DK3823972T3
DK3823972T3 DK19745231.1T DK19745231T DK3823972T3 DK 3823972 T3 DK3823972 T3 DK 3823972T3 DK 19745231 T DK19745231 T DK 19745231T DK 3823972 T3 DK3823972 T3 DK 3823972T3
Authority
DK
Denmark
Prior art keywords
imidazo
pyridazine derivatives
trk inhibitors
trk
inhibitors
Prior art date
Application number
DK19745231.1T
Other languages
English (en)
Inventor
Alan Brown
Angela Glen
Original Assignee
Benevolentai Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Benevolentai Bio Ltd filed Critical Benevolentai Bio Ltd
Application granted granted Critical
Publication of DK3823972T3 publication Critical patent/DK3823972T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19745231.1T 2018-07-19 2019-07-19 Imidazo[1,2-b]pyridazinderivater som trk-inhibitorer DK3823972T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1811825.7A GB201811825D0 (en) 2018-07-19 2018-07-19 Organic compounds
PCT/GB2019/052021 WO2020016594A1 (en) 2018-07-19 2019-07-19 Imidazo[1,2-b]pyridazine derivatives as trk inhibitors

Publications (1)

Publication Number Publication Date
DK3823972T3 true DK3823972T3 (da) 2022-10-03

Family

ID=63364331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19745231.1T DK3823972T3 (da) 2018-07-19 2019-07-19 Imidazo[1,2-b]pyridazinderivater som trk-inhibitorer

Country Status (20)

Country Link
US (1) US20210277008A1 (da)
EP (1) EP3823972B1 (da)
JP (1) JP2021530532A (da)
KR (1) KR20210035225A (da)
CN (1) CN112823160A (da)
AU (1) AU2019304141A1 (da)
BR (1) BR112021000878A2 (da)
CA (1) CA3106430A1 (da)
DK (1) DK3823972T3 (da)
EA (1) EA202190322A1 (da)
ES (1) ES2928494T3 (da)
GB (1) GB201811825D0 (da)
HU (1) HUE060319T2 (da)
IL (1) IL280122A (da)
MA (1) MA53165A (da)
MX (1) MX2021000683A (da)
PT (1) PT3823972T (da)
SG (1) SG11202100337RA (da)
WO (1) WO2020016594A1 (da)
ZA (1) ZA202100158B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201813791D0 (en) * 2018-08-23 2018-10-10 Benevolental Bio Ltd Organic compounds
EP4093376A1 (en) * 2020-01-22 2022-11-30 BenevolentAI Bio Limited Pharmaceutical compositions and their uses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
US7241776B2 (en) * 2004-08-02 2007-07-10 Abbott Laboratories Cyanoamidine P2X7 antagonists for the treatment of pain
ES2548135T3 (es) * 2008-05-13 2015-10-14 Novartis Ag Heterociclos condensados que contienen nitrógeno y composiciones de los mismos como inhibidores de quinasa
RS53350B (en) * 2008-09-22 2014-10-31 Array Biopharma, Inc. SUBSTITUTED COMPOUNDS OF IMIDASO [1,2-B] PYRIDASINE AS INK KINASE INHIBITORS
UY33597A (es) * 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
CN108329246B (zh) 2011-05-13 2021-02-26 阵列生物制药公司 作为trka激酶抑制剂的吡咯烷基脲和吡咯烷基硫脲化合物
JP5990595B2 (ja) 2011-12-12 2016-09-14 ドクター レディズ ラボラトリーズ リミテッド トロポミオシンレセプターキナーゼ（Ｔｒｋ）阻害剤としての置換されたピラゾロ［１，５−ａ］ピリジン
WO2013161919A1 (ja) 2012-04-26 2013-10-31 小野薬品工業株式会社 Ｔｒｋ阻害化合物
WO2014026327A1 (en) * 2012-08-15 2014-02-20 Merck Sharp & Dohme Corp. 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
WO2015039333A1 (en) * 2013-09-22 2015-03-26 Merck Sharp & Dohme Corp. TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
US9394305B2 (en) * 2014-06-23 2016-07-19 Dr. Reddy's Laboratories Ltd. Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors
EP3233863B1 (en) 2014-12-15 2024-04-10 CMG Pharmaceutical Co., Ltd. Fused ring heteroaryl compounds and their use as trk inhibitors

Also Published As

Publication number Publication date
PT3823972T (pt) 2022-10-03
MX2021000683A (es) 2021-05-31
EA202190322A1 (ru) 2021-06-28
ZA202100158B (en) 2023-06-28
HUE060319T2 (hu) 2023-02-28
US20210277008A1 (en) 2021-09-09
JP2021530532A (ja) 2021-11-11
EP3823972A1 (en) 2021-05-26
EP3823972B1 (en) 2022-09-07
AU2019304141A1 (en) 2021-02-04
IL280122A (en) 2021-03-01
SG11202100337RA (en) 2021-02-25
WO2020016594A1 (en) 2020-01-23
MA53165A (fr) 2021-05-26
CA3106430A1 (en) 2020-01-23
BR112021000878A2 (pt) 2021-04-13
ES2928494T3 (es) 2022-11-18
CN112823160A (zh) 2021-05-18
GB201811825D0 (en) 2018-09-05
KR20210035225A (ko) 2021-03-31

Similar Documents

Publication Publication Date Title
DK3523301T3 (da) Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer
DK3523302T3 (da) Substituerede pyrazolo[1,5-A]pyridin-forbindelser som RET-kinase-inhibitorer
DK3583105T3 (da) Pyrrol[1,2-b]pyridazinderivater
DK3846904T3 (da) 5-morpholin-4-yl-pyrazolo[4,3-b]pyridinderivater
DK3558990T3 (da) Tetrahydroimidazo[4,5-c]pyridinderivater som pd-l1 internaliseringsinducere
DK3419978T3 (da) Pyrazolo[1,5-A]pyrazin-4-yl-derivater som JAK-hæmmere
DK3429591T3 (da) Substituerede thieno[2,3-D]pyrimidin-derivater som inhibitorer af Menin-MLL og fremgangsmåder til anvendelse
DK3840832T3 (da) Imidazo[1,2-b]pyridaziner som trk-inhibitorer
DK3611174T3 (da) [1,2,4]triazolo[1,5-c]pyrimidinderivat som a2a-receptorinhibitor
DK3371185T3 (da) 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus-kinase-inhibitorer
DK3712152T3 (da) 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus kinase-inhibitorer
DK3880676T3 (da) 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-on-derivater som hpk1-inhibitorer til behandling af cancer
DK3077397T3 (da) 2-amino-6-fluor-n-[5-fluor-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamidforbindelse anvendelig som atr-kinase-inhibitor, dens fremstilling, forskellige faste former og radiomarkerede derivater deraf
DK3478681T3 (da) 1h-pyrazolo[4,3-b]pyridiner som pde1-inhibitorer
EP3452481A4 (en) IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS
DK3870574T3 (da) Aminopyridin/pyrazinderivater som ctps1-inhibitorer
DK3679042T3 (da) Imidazo[1,5-A]pyrazin-derivater som PI3Kdelta-inhibitorer
IL269214B (en) Novel imidazo[5,4-c]quinoline derivatives as lrrk2 inhibitors
CL2017001543A1 (es) Formulaciones farmacéuticas de inhibidores de la cinasa relacionada con tropomiosina (trk)
EP3551630A4 (en) IMIDAZO [1,5-A] PYRAZINE DERIVATIVES AS PI3KDELTA INHIBITORS
DK3952995T3 (da) Bicykliske heteroarylderivater som ectonukleotidpyrophosphatase-phosphodiesterase-1-hæmmere
ZA202100259B (en) Pyrrolo[1,2-b]pyridazine derivatives
DK3083627T3 (da) [1,2,4]triazol[1,5-a]pyrimidinderivater som protozoiske proteasominhibitorer til behandling af parasitsygdomme, såsom leishmaniasis
IL280122A (en) Imidazo[2,1-B]pyridazine derivatives as TRK inhibitors
DK3218382T3 (da) 2,3-dihydro-thiazolo[3,2-a]pyridin-5-on derivativer som antibiotika til behandling af klamydiainfektioner